Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34930
Title: Drug survival analysis of tofacitinib in patients with rheumatoid arthritis
Authors: Uludağ Üniversitesi/Sağlık Bilimleri Enstitüsü/Biyoistatistik Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.
Karakoç, Yenal
Ercan, İlker
ABF-2367-2020
Keywords: Rheumatology
Issue Date: Jun-2018
Publisher: BMJ Publishing Group
Citation: Karakoç, Y. ve Ercan, İ. (2018). ''Drug survival analysis of tofacitinib in patients with rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 1411-1411.
Description: Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.
URI: https://doi.org/10.1136/annrheumdis-2018-eular.1893
https://ard.bmj.com/content/77/Suppl_2/1411.1
http://hdl.handle.net/11452/34930
ISSN: 0003-4967
1468-2060
Appears in Collections:Web of Science

Files in This Item:
File Description SizeFormat 
Karakoç_ve_Ercan_2018.pdf181.33 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons